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Abstract 
Background. Trials of complex interventions are associated with high costs and burdens in 
terms of paperwork, management, data collection, validation, and intervention fidelity 
assessment occurring across multiple sites. Traditional data collection methods rely on 
paper-based forms, where processing can be time consuming and error rates high. 
Electronic source data collection can potentially address many of these inefficiencies, but 
has not routinely been used in complex intervention trials. Here we present the use of an 
on-line system for managing all aspects of data handling and for the monitoring of trial 
processes in a multi-centre trial of a complex intervention.  
Methods.  We custom built a web-accessible software application for the delivery of 
ENGAGE-HD, a multi-centre trial of a complex physical therapy intervention. The software 
incorporated functionality for participant randomisation, data collection and assessment of 
intervention fidelity.  It was accessible to multiple users with differing levels of access 
dependent on required usage or to maintain blinding. Each site was supplied with a 4G 
enabled iPad for accessing the system. The impact of this system was quantified through 
review of data quality and collation of feedback from site co-ordinators and assessors 
through structured process interviews. 
Results. The custom-built system was an efficient tool for collecting data and managing trial 
processes. Although the set-up time required was significant, using the system resulted in 
an overall data completion rate of 98.5% with a data query rate of 0.1%, the majority of 
which were resolved in under a week. Feedback from research staff indicated that the 
system was highly acceptable for use in a research environment. This was a reflection of the 
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portability and accessibility of the system when using the iPad and its usefulness in aiding 
accurate data collection, intervention fidelity and general administration.  
Conclusions. A combination of commercially available hardware and bespoke online 
database designed to support data collection, intervention fidelity and trial progress 
provides a viable option for streamlining trial processes in a multi-centre complex 
intervention trial. There is scope to further extend the system to cater for larger trial and 
add further functionality, such as automatic reporting facilities and participant management 
support. 
Trial Registration: ISRCTN65378754 13th March 2014 
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Background 
Running a multi-centre complex intervention trial generates significant trial 
management demands both centrally and in local teams independent of the complexity of 
the trial design. Complex intervention trials are likely to require data collection via multiple 
formats in order to monitor and record multiple and differing aspects of the intervention 
[1]. These may include the more traditional paper case report forms (CRFs), video 
observations and audio recordings, the latter usually requiring multiple pieces of specialist 
equipment, all contributing to increased costs. Complex interventions also require some 
degree of assessment of how accurately the intervention is delivered to ensure consistency 
of delivery across multiple sites. Again this can be costly in terms of personnel hours 
required and can contribute to the general inefficiency of a trial.  
Paper CRFs remain the most widely used data collection tool and are perceived to be 
quick to implement and relatively simple to manage [2] . Benefits of using paper CRFs 
include the ease of testing, distribution to sites and simplicity at the point of study closure 
and archiving. However, the need for transcription to electronic systems and/ or 
photocopying of paper CRFs for sending to the trial centre is costly and introduces likely 
avenues for error and duplication of effort [3]. Further, lengthy monitoring visits may be 
required to ensure the quality and appropriateness of the data being collected, 
necessitating comparison of transcribed records against the original source material. A 
move to electronic source CRF (eSource) data collection provides a method for reducing this 
burden. Initial set-up can be time consuming, however, and additional training is often 
required for correct usage [3]. Currently, eSource data collection has failed to replace 
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traditional paper CRFs in most complex intervention trial environments, although the use of 
web-accessible data capture methods to improve trial efficiency is an area of emerging 
interest  
Our aim was to use modern and portable eSource technologies to improve many of 
the management and data collection errors and inefficiencies that are often experienced in 
complex intervention trials, and to test this in a small scale study. ENGAGE-HD is a multi-
centre, single blinded complex intervention trial of a complex physical activity intervention 
iŶ HuŶtiŶgtoŶ͛s disease ǁhere the iŶterǀeŶtioŶ ǁas deliǀered at the partiĐipaŶt͛s hoŵe. 
Trial assessments are performed over three time points at eight sites across the UK[4] 
Although a relatively small trial, there were a number of specific complexities that made this 
a good case study candidate for establishing proof of principle for such a system: each site 
had a co-ordinator, one or more coaches for the physical and social (control) intervention 
and assessors blinded to the arm allocation of the participant. Briefly site coordinators 
scheduled appointments and visits, aided data collection and acted as the main point of 
contact for the central study team. The blinded assessors conducted the evaluations for the 
primary trial outcomes at three time points in a hospital-based setting, with each 
assessment requiring the completion of 9-15 individual CRFs. The intervention coaches 
visited participants at their home on six occasions between assessments 1 and 2 where they 
were required to deliver the intervention and collect weekly diary data from participants. 
Therefore, data collection needed to be as efficient as possible to maximise data capture 
across all settings and time points.  In this paper we describe the system development, 
implementation and methods to capture impact of a custom-designed web-based system 
developed with the intention of streamlining trial processes in ENGAGE-HD.  
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Methods 
System Development-  
The web-based system for ENGAGE-HD was designed to be a robust, intuitive and 
flexible system with the primary aim of aiding trial management and data collection. We 
incorporated a number of differing functional modules into the system which provided a 
facility for monitoring and assessing intervention fidelity and for performing the 
randomisation of participants. Development took a period of three months, encompassing 
alpha testing, which focussed on the initial look and feel of the system and beta testing 
which focussed on the user acceptability of the system. Development and testing was 
undertaken by an in house software developer at an approximate cost of £7,250, with data 
manager input at an approximate cost of approximately £9134 for the initial development. 
We estimate that the developer provided maintenance and ongoing support for 3 hours 
over the duration of the recruitment period which was an additional cost of £3782. This 
culminated in primarily eSource data collection, with the option of using paper CRFs where 
desired or required. All system users were issued with their own username and password to 
access the facility with differing levels of permissions conferred to individual users 
dependent on their role. For example, the blinding of assessors was maintained by denying 
them access to participant allocation information and the intervention coaches were given 
specific access to upload audio recordings to the database and to access a summary report 
of the subsequent fidelity evaluation. 
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The platform was created to be accessible through desktop computers and tablet 
devices to allow for maximum functionality and real time data capture.  However, where 
site staff felt more comfortable with completing paper CRFs, the software was designed so 
that the CRF could be generated as a PDF directly from the platform and printed for manual 
use. The software was also built to enable participant randomisation after the completion of 
the initial assessment without the need to contact the central study team and also allowed 
for real time data entry during home visits and assessments.  Randomisation was performed 
using minimisation [5] in order to balance between groups based on data obtained at the 
ďaseliŶe assessŵeŶt (age, seǆ aŶd UŶified HuŶtiŶgtoŶ͛s Disease ‘atiŶg “Đale- Total Motor 
Score (UHDRS-TMS).  
The software added extra functionality as a data collection tool with in-built data 
validation rules to minimise errors at the point of data entry. With controllable format of 
data entry fields, data could only be entered in the correct format, and values outside of 
pre-specified ranges generated a warning message to alert the researcher before the form 
was saved. The system was also engineered with the capability to upload audio recordings 
for fidelity assessment.  Intervention coaches could record the audio of their interaction 
with the participant using the iPad, which was then securely uploaded to the database 
before being deleted according to data protection strictures. The audio recording was rated 
for fidelity of the delivery of the intervention in line with the theoretical framework on 
which it was developed [6]. Feedback from the intervention trainer was delivered to 
intervention coaches via Skype® on the tablet device.  
The software design automatically stored inputted data in a structured query 
language (SQL) database, from which interim extracts could be made available on demand. 
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Further design aspects enabled the central study team to receive e-mail alerts once 
assessment data had been submitted so that data queries could be raised and resolved in a 
timely fashion. Any changes made to the data forms after original submission were 
automatically saved, logging all details required by good clinical practice (GCP) 
requirements: the user who made the change, the date of the change and the values before 
and after the change. 
Device Configuration 
The web-based system was intended to be accessible to researchers in real time so 
we decided to invest in portable, web-enabled devices to make this possible.  A number of 
factors were considered in the choice of device to be used in the trial. These ranged from 
availability, cost, portability and security to the ease and acceptability of use in the trial 
setting. We concluded that the device which would offer the best compromise over all was 
the iPad Air® as it is a widely used device, with uniform interface design across most 
applications and would require the least amount of additional training for users. The ability 
to use the video-conferencing software Skype® and integrated video and audio recording 
meant that a single device had all the required functionality to perform all trial-related tasks 
at site. All devices were configured to use a secure Wi-Fi connection where available or to 
fall back on 4G data services, which allowed reliable connectivity at all research sites.  
Implementation 
Prior to implementation at research sites, the system was fully tested and validated 
using all devices and interfaces that would be used as part of the trial. Each site was visited 
by the central study team for staff training in using the iPad, uploading data through the 
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web-site and the use of the supplementary software packages.  Checks were also carried out 
on the availability of secure Wi-Fi access and cellular network coverage.  Each site was 
required to provide their agreement to use the device and system as instructed and to 
maintain device updates where necessary.  Support and additional training was also given 
through e-mail and telephone contact with the trial manager on a needs basis. 
Methods to capture Impact 
Our evaluation of the impact of the system was based on two principal criteria, 1) 
trial data quality and (2) user feedback.  To assess data quality, we made comparison of the 
number of data queries raised to the number of data items entered and the time taken to 
resolve data queries. We also descriptively summarised the proportion of missing data items 
in the minimum dataset. We also noted how many sites were using paper CRFs by the third 
and final participant assessment.  
Feedback was obtained through structured telephone interviews with members of 
research staff from across the 6 of the 8 sites involved in the trial. We aimed to get feedback 
from at least one person per site who had used the database. We were able to conduct 
interviews with 6 members of site staff which included; two intervention coaches, three site 
coordinators (one of whom also acted as a coach) and one blinded assessor. Interviews 
consisted of a pre-determined set of ten questions covering topics such as the usability and 
accessibility of the system and support requirements. Interviews were conducted by the 
database developer and responses to questions were recorded verbatim in real time.  
Responses were summarised according to the questions asked  using the method of 
qualitative description [7]-8].  
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Trial Participants 
Target recruitment for ENGAGE-HD inflated for losses to follow up was 62, requiring 46 for 
final analysis. 46 participants were recruited (n=25 male and n=21 female). Mean age was 
59.4 years (Standard deviation (SD) 10.1).  
Ethics and consent  
 ENGAGE- HD was approved by the Wales Research Ethics Committee 2 on the 26th 
February 2014 (REC reference, 14/WA/0034). This trial was conducted in accordance with 
the declaration of Helsinki. All participants gave fully informed consent before taking part in 
this study. 
Results  
Training and on-site support 
  The development of our bespoke, purpose-built electronic trial management system 
required intensive resource in the initial set-up period.  Significant time was needed to 
accurately write all the necessary metadata, which included the use of in-built validation 
rules to prevent the entry of erroneous data. Although not formally recorded, we estimate 
that the development of the database required 12 weeks of data manager time and 
approximately 10 weeks of developer time, running concurrently, to build and sufficiently 
test the system. 
 The initial site set-up process required intensive training during the initiation visit. In 
addition to standard site initiation tasks, an extra 1-2 hours was set aside to familiarise key 
staff with the use of the iPad and the functions of the ENGAGE-HD database. The 
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requirement for additional training differed between individual sites, based largely on staff 
familiarity with using iPads or other electronic tablet devices.  Step-by-step guides were 
produced to help staff with the use of additional applications required for audio and video 
recording. Further support (via e-mails and phone calls) was also sometimes required during 
the initial months after recruitment began, until staff were sufficiently confident with using 
the system.  
Data Quality 
 We evaluated the impact of the system on data collection and quality by looking at 
the completeness and quality of the data that was received through the database. Table 1 
shows the number of completed electronic CRFs broken down by individual study sites. Two 
sites achieved a completion rate of 100%, with the site returning the fewest completed 
forms still achieving a completion rate of 96%. Across the study, 2,639 of 2,678 CRFs were 
successfully completed, giving an overall return rate of 98.5%. Individual sites were chased 
for missing CRFs on multiple occasions which was monitored monthly by the trial 
management group. After a period of approximately three months, as none of the data 
contained in the missing CRFs were critical for the primary trial analysis, the trial 
management committee decided to record these 1.5% of non-returned CRFs as missing 
data.   
 We were also able to assess the number of data queries per site and the median 
time it took to resolve those data issues. Overall there were 141 data queries for the whole 
trial, which were resolved in a median time of 3 days (Table 1). All but one site routinely 
resolved data queries within one week of the query being raised. We calculated that for 
participants in the physical intervention there would be a total of 3134 data points across 
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the whole trial and 1674 for participants in the social arm. Assuming all participants 
completed the trial as intended and all CRFs were completed, this would give a total of over 
100,000 individual data points. Therefore, the number of data queries raised across the trial 
constitutes approximately 0.1% of all the data entered for the trial. 
 To help assess fidelity, coaches in the intervention arm were also asked to audio-
record one of their home-visits, using an in-built iPad application and then upload that file 
to the study team through the ENGAGE-HD database. Sixteen participants completed the 
intervention, and in all cases the coaches successfully uploaded an audio recording via the 
ENGAGE-HD database.  Audio recordings captured by the iPad device were of sufficient 
sound quality to be accurately transcribed, and formed the basis of further fidelity analysis 
reported elsewhere [6]. 
 Lastly, we reviewed the reported protocol deviations for the trial to assess the 
impact of the database on protocol adherence. Out of the 30 protocol deviations reported 
for the ENGAGE-HD trial, three were related to the use of the database. Two incidents could 
be attributed to user error: the wrong age category was selected on the randomisation 
form, and one audio recording was not uploaded to the database within 48 hours of being 
taken so it could be deleted from the iPad. The other incident was a case where the blinded 
assessor had difficulty accessing the database and was unable to upload the baseline 
information immediately. Although the data was recorded on back-up paper copies, the 
process lead to a delay in the randomisation of the participant so that they were not 
informed of their group allocation until a number of days after the assessment.  The other 
incidences of protocol deviations were largely attributed to scheduling issues or intra-site 
communications leading to the unblinding of assessors. 
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User Impact 
We considered the impact of the integrated system on both the trial staff and the 
site staff. For trial staff, one of the major advantages we found with using this system was 
that it allowed real-time monitoring of the progress of the trial and of individual 
participants. The database was programmed to send e-mail alerts to the trial and data 
manager as soon as participant assessment data had been entered. This enabled prompt 
review of the data collected, allowing swift generation and resolution of data queries, as 
described above. Further, this level of access allowed the central study team to monitor the 
progress of intervention visits and flag if there were any obvious delays. If such a problem 
was noted, communication with the site could be initiated immediately to offer further 
support and advice if required. 
We performed semi-structured interviews with a mix of site staff (n=6) involved in 
ENGAGE-HD to investigate their views on the impact of the database system on the delivery 
of the study.   A summary of the results from these interviews can been in Table 2.  
One interviewee was new to the collection of trial data, but the remainder had 
performed similar work before and they all indicated that the majority of data collection 
was using traditional paper CRFs.  Three people mentioned that data collected on paper 
CRFs was then entered on to a database via a desktop PC and a further person said that they 
had worked on studies previously where data was uploaded directly into a database.  
Half of the staff interviewed indicated that their experience of using iPads was 
limited and although the remainder had experience through personal use, no one had 
previously used an iPad in a work context.  
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 All respondents were extremely positive about the training they received for using 
the iPad and database. All respondents stated that the training and support they received 
was adequate and no-one had any suggestions for improvements. Specific responses 
highlighted that queries were responded to quickly, the standard operating procedures 
(SOPs) provided were clear and easy to follow and that the site initiation training was good. 
Half of the staff interviewed (n=3) also singled out that efficient management of the trial 
was important in how well supported they felt.  
 To gain more specific perspectives of site staff, we asked them to describe the 
relative advantages and disadvantages of fully eSource data collection using the supplied 
iPad. The summary of responses can be found in Table 2 and included benefits such as ease 
of use and data collection, mobility of use and the ability to use additional apps to facilitate 
the work. Some of the drawbacks mentioned included limited battery life, only having one 
device per site, and that on-line forms could be re-designed to allow more feedback. 
 All interviewees said that they took advantage of some the additionally functionality 
(Skype®, audio recording, camera, e-mail) of using an iPad. The specific apps and the 
amount they were used were dependent on the research role of the specific interviewee. 
Intervention coaches particularly liked the use of the audio recording and Skype® functions 
to discuss and receive feedback on the delivery of the intervention with the intervention 
trainer. Site co-ordinators employed the use of the camera to take high resolution images of 
documents which could then be e-mailed securely to the coordinating centre. 
 Lastly, we asked the site staff if their experience of using the iPad and database for 
ENGAGE-HD had influenced their views on working on trials in the future.  The response to 
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this was overwhelmingly positive, with the move to paperless systems being particularly 
popular, although it was noted that different studies would have specific requirements. 
  Overall the feedback of the research staff interviewed on the use of the iPad and 
database for delivering ENGAGE-HD demonstrated high levels of acceptability to site users. 
Discussion 
Through this case study, we have demonstrated that is possible to produce reliable, 
web accessible software for the purposes of data collection and management and trial 
management in a multi-site trial of a complex intervention.  The return rate and quality of 
data collected was particularly high and the system had high user acceptability ratings. The 
use of the system also allowed for efficient trial management by enabling sites to perform 
randomisation of participants themselves and by reducing the need for extensive and 
repeated on-site data monitoring, which offset the initial intensive training required during 
site set up. 
The system we designed facilitated the immediate collection of source data during 
study visits and assessments via use of the iPad, negating the need for secondary data 
transcription once it had been collected. It seems likely that this portable collection facility, 
which incorporates prompts and validation checks in real time, ensured that the overall 
form completion rate for the trial was high. Importantly, the software enabled the facility to 
provide paper back-ups of all CRFs when access to the live system was not possible or 
desired and as such data collection was not compromised. 
Data validation rules that were embedded into the software ensured that the 
accuracy of completed eSource data was high, resulting in a low administrative burden in 
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terms of generating and resolving data queries. This specific database design feature 
allowed us to be confident that when assessment data had been entered and checked the 
data was sufficiently clean for analysis, thereby negating the need for lengthy data cleaning 
once the trial was finished. We believe that this time-saving efficiency more than 
compensated for the higher additional set-up time required for developing and 
programming the software. Additionally, the combination of high levels of data completion 
and accuracy along with the efficient site communication meant that intensive site-
monitoring visits were not deemed necessary to ensure the efficient delivery of the trial.  
The lack of multiple copies of paper CRFs in this trial also conferred other benefits. 
Firstly, archiving at sites can be problematic due to constraints on space in suitable facilities. 
The reduction in the volume of paperwork generated in ENGAGE-HD through the 
implementation of a largely paperless system is therefore an important consideration. 
Secondly, we were able to reduce the number of costly site monitoring visits, due to 
decreased need to carry out quality control inspections of paper records against the 
transcribed copies on digital systems. 
The use of this web-based system in ENGAGE-HD had added benefits beyond data 
collection. The randomisation was embedded in the program ensuring that participants 
could be effectively randomised on the day of their screening assessment without the need 
for contacting the coordinating centre. This feature reduced the timelines of progressing 
any given participant through the trial by removing the need for staff at the sites and the 
coordinating centre to communicate directly. Remote and automated randomisation in 
itself is not novel and the approach has been published elsewhere [9]- 11] as an effective 
method for allocating participants, but to our knowledge it has not previously been 
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embedded within the study data collection system alongside other trial monitoring and 
management features. Perhaps, the most important design feature of the ENGAGE-HD 
database was the integrated method for fidelity monitoring, a vital aspect of delivering 
complex interventions. This allowed rapid assessment of the fidelity of the intervention 
delivery by all coaches with all participants in the physical intervention arm and for useful 
feedback to be delivered in a useful and timely fashion. For all participants in the 
intervention arm, an audio recording was successfully uploaded for fidelity assessment, 
which indicates the utility of the database for this process. Additionally, the individualised 
permissions settings designed for each user enabled intervention coaches to access 
confidential feedback on their delivery of the intervention through the system, which they 
could refer back to at any time. We believe this aspect of the system was key to the high 
levels of intervention fidelity in the trial which we have reported elsewhere [6].  
It was important to gain the perspectives of end users of the database who were not 
involved in its development to determine the acceptability of the technology in a research 
environment. If end users are not comfortable or satisfied with the data collection and 
management modules, they will either not engage with using the system or, if enforced, 
their use maybe more inefficient and less accurate. In general, the feedback we received 
from site staff through the telephone interviews conducted was positive and the move from 
paper CRF data collection to eSource was widely welcomed. Intervention coaches were 
particularly receptive to the use of Skype® and audio recordings for fidelity monitoring and 
found the feedback received useful for intervention delivery [6].  
Some staff had reservations about using the iPad and navigating the database whilst 
assessing participants, but we found that additional support and training from the 
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coordinating centre alleviated these fears.  Further, the feedback we received revealed the 
additional benefit of using an iPad on a cellular network was in part that it was unaffected 
by many of the security features present on NHS networks, which prevent the use of some 
web-enable applications such as Skype®.  
This case study provides preliminary indications that our system was indeed 
beneficial to trial processes.  We do however acknowledge that our evaluation of impact 
could have been strengthened by obtaining a wider range of perspectives. A better 
approach would have been to conduct face-to face interviews with site staff rather than rely 
on a structured telephone interview. 
We note that a major limitation in the evaluation of the system as a whole is the lack 
of comparator (such as a purely paper-based system), which is necessary to draw firm 
conclusions about the efficiency of our system. ENGAGE-HD was a feasibility trial of a 
complex intervention and we did not plan to formally evaluate the efficacy of our system in 
reducing data queries or data cleaning. In spite of differential data queries rates across our 
sites, the overall data return rate across all ENGAGE-HD sites was however similar, 
furthermore the real-time monitoring of data and in built data validations to our system 
meant that data cleaning occurred automatically. This suggests that the system described 
here provides the added advantage of site support during data collection but are not able to 
confirm this without a full scale comparative evaluation.  We await, with interest,  the 
results of the TRANSFoRM study which is currently evaluating the utility of an electronic 
platform, in the recruitment and follow up of participants in primary care research [10] as 
this is likely to provide more support for the approach we describe here.  
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Whilst we found that the use of the on-line database and portable technologies in 
the delivery of ENGAGE-HD were largely beneficial, we recognise that this system had 
limitations. In order for the system to be functional, internet access is required at all times, 
therefore secure Wi-Fi or adequate cellular coverage must be available. We 
circumnavigated this issue by purchasing 4G enabled tablet devices, but recognise that this 
adds a significant extra cost. Although lack of accessibility was an initial concern, we 
resolved this by ensuring that paper copies could be obtained without internet access. This 
ensured that accessibility did not become an issue during the trial.   
One of the aims of the ENGAGE-HD trial was to design and implement an on-line 
system to streamline processes associated with fidelity monitoring, participant 
randomisation, site communication and data collection in a multi-centre complex 
intervention trial. Electronic data capture is becoming increasingly popular as a method of 
data acquisition in clinical trials for reducing both the time and costs required to deliver a 
study[12][13], but the number of studies using such applications remains comparatively 
small [14]. Current methods of electronic data capture usually require the transcription of 
paper records to eSource via manual input or scanning technologies, both of which can 
introduce error and a significant time burden on the research team. With both of these 
methods, data still needs to be checked for accuracy and validity, further adding to trial 
running costs. Such processes contribute to general inefficiencies in trials where large 
amounts of data are being collected [15]. Additional time saving benefits of automated trial 
processes and data collection compared to traditional paper CRF methods and management 
are being increasingly recognised in industry-sponsored trials[16][17][12].   
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For future versions of a similar trial database, we would like to investigate the 
addition for further functional modules that could further reduce time burdens in 
administration and recording of necessary documentation. For example, we found that 
although protocol deviations were reported in a timely fashion, there were significant 
delays in receiving the necessary signed documentation. We believe that by transferring this 
process to an on-line facility, documentation would be completed in a more timely fashion.  
Similarly we would integrate screening logs and safety reporting into future versions of the 
database to improve the speed of documentation return and improve consistency between 
sites.  
In this trial we continued to monitor outcome data as it was uploaded to check 
accuracy and completeness. As a result, future iterations should take further time during the 
set up period to add iŶ additioŶal, striĐter ǀalidatioŶ rules or ͚flags͛ for speĐifiĐ outĐoŵes. A 
flagging system could be incorporated so that data outside of accepted normative values 
could produce a prompt to check the validity of the data entered. Coupled ǁith ͚free teǆt͛ 
sections where those entering data could add further detail and explanation, this would 
preǀeŶt largelǇ erroŶeous data froŵ ďeiŶg eŶtered aŶd reduĐe the Ŷeed for ͚ďǇ eǇe͛ data 
monitoring. Further, an investment in developing robust data validations at the outset can 
be realised in subsequent trials where metadata can be simply and reliably replicated 
Conclusions 
Here we have demonstrated that the use of portable and real-time technologies at 
the researcher-participant interface in a multi-centre complex intervention trial is a viable 
and efficient method for improving trial management and data collection procedures. There 
is scope to extend the system further by adding other functional modules to aid in other 
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aspects of trial management. This includes schedule planning, automatic compliance, safety 
reporting and dissemination of trial documentation updates. Although assessing the validity 
of such a system in a larger scale trial is still required, the success of this system in ENGAGE-
HD has provided a basis for an accessible, secure platform for the refinement and delivery of 
complex intervention trials.  
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Table 1. Completion of electronic case report forms and the number of data queries by study 
site. 
Study 
site 
No. of 
participants 
recruited 
No. of 
required 
CRFs 
No. of 
completed 
CRFs 
Completed 
CRFs         
(% total) 
No. of 
Data 
Queries 
Median time to 
query resolution 
(days) 
1 10 654 643 98.3 22 4 
2 2 124 120 96.8 6 1.5 
3 4 239 237 99.2 22 1 
4 5 325 325 100.0 18 1.5 
5 6 337 337 100.0 22 6 
6 4 241 240 99.6 8 19 
7 10 576 563 97.7 18 2 
8 5 182 174 96.0 25 2 
Total 46 2,678 2,639 98.5 141 3 
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Table 2.Summary of feedback responses given by ENGAGE-HD research staff in semi-
structured interviews. 
Question Response Number of 
Respondents 
Have you previously collected 
research data for studies? If yes, 
how did you collect the data? 
No 1 
Yes, mainly using paper CRFs 1 
Yes, using paper CRFs then entered 
into a database 
4 
What was your experience of 
using an iPad prior to your work 
on ENGAGE-HD? 
None 1 
Limited  2 
Personal use 4 
What as your experience of using 
an iPad on ENGAGE –HD? 
Positive 6 
What were some of the 
advantages? 
Mobility/ ability to be able to work 
across NHS and other sites. 
4 
Ease of use 5 
Facilitation of data entry 3 
3G/ Signal 2 
In-built data validations 1 
Ability to use additional apps 3 
What were some of the 
disadvantages? 
None 1 
System crashed once 1 
Repeated log-ons (at each visit to 
the database web page) slowed 
process 
1 
Only one device per site 1 
Form design not optimum (for giving 
feedback and because of repetitive 
data entry).  
2 
Poor battery life 1 
Did you use the added 
functionality of the iPad during 
the trial? If so how? 
No 0 
Yes Skype 5 
Camera for photographing 
documents 
2 
Audio recording 4 
Secure e-mail 2 
Was the support you were given 
adequate? 
No 0 
Yes 6 
Has the use of the iPad on 
ENGAGE-HD influenced your 
view on working with it in clinical 
trials in future? 
Not really 1 
Yes Would use in future studies 3 
A useful option 1 
But might not work for all 
studies such as text heavy 
qualitative studies etc. 
1 
 
